SCHEMBL5262439

SCHEMBL5262439

CC(Cc1cc(CNC(=O)O)cc(C(C)(C)C)c1)Nc1nccc(N(C)c2ccnc(Cl)n2)n1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 13/20 0.35
▸ IDH1 O75874 6/20 0.34
▸ AURKA O14965 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5264280 0.88 MAPK14 (0.40) MAPK14AURKA
SCHEMBL5261120 0.87 MAPK14 (0.38) MAPK14AURKA
SCHEMBL5914251 0.79 BRD4 (0.38) MAPK14
SCHEMBL5914249 0.79 BRD4 (0.38) MAPK14
SCHEMBL5914399 0.77 MAPK14 (0.36) MAPK14AURKA
SCHEMBL5914118 0.76 MAPK14 (0.42) MAPK14AURKA
SCHEMBL5914082 0.73 MAPK14 (0.39) MAPK14
SCHEMBL5314959 0.73 MAPK14 (0.40) MAPK14
SCHEMBL5914162 0.73 HPGDS (0.40) MAPK14IDH1
SCHEMBL5314967 0.73 MAPK14 (0.40) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794135-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-06-13 — — EP disclosed
WO-2006037117-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2006-04-06 — — WO disclosed
Send feedback